This inventor holds 1 USPTO granted patent. Top assignee: Universität Zu Koln. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Georg Pongratz: Innovator in Diagnosing Degenerative Diseases
Introduction
Georg Pongratz is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of autoantibodies related to degenerative diseases of the skeletal system. His innovative work aims to improve the diagnosis and treatment of conditions such as arthritis.
Latest Patents
Georg Pongratz holds a patent for the "Detection of autoantibodies for diagnosing degenerative diseases of the skeletal system." This patent includes methods, kits, and active ingredients for diagnosing or treating arthritis or degenerative diseases of the skeletal system. The methods involve detecting an autoantibody associated with arthritis or excluding the presence of an autoantibody against collagen II. Additionally, the methods for diagnosing degenerative diseases involve detecting an autoantibody against thrombospondin-4 or COMP. The kits developed contain a detection agent for an autoantibody and can be utilized for diagnosing arthritis or degenerative diseases. The active ingredient can be used for treating or preventing autoimmune-associated arthritis. He has 1 patent to his name.
Career Highlights
Georg Pongratz is affiliated with the University of Cologne, where he continues to advance research in his field. His work has been instrumental in developing diagnostic methods that can significantly impact patient care and treatment outcomes.
Collaborations
Some of his notable coworkers include Andreas R Klatt and Johannes Ruthard. Their collaborative efforts contribute to the ongoing research and development in the area of autoimmune diseases.
Conclusion
Georg Pongratz is a pioneering inventor whose work in diagnosing degenerative diseases has the potential to transform medical practices. His contributions to the field are invaluable and continue to inspire advancements in healthcare.